LONDON SKIN MED MARCI LTD

Company Registration Number:
14538924 (England and Wales)

Unaudited statutory accounts for the year ended 31 December 2023

Period of accounts

Start date: 13 December 2022

End date: 31 December 2023

LONDON SKIN MED MARCI LTD

Contents of the Financial Statements

for the Period Ended 31 December 2023

Company Information - 3
Report of the Directors - 4
Profit and Loss Account - 5
Balance sheet - 6
Additional notes - 8
Profit and Loss notes - 11

LONDON SKIN MED MARCI LTD

Company Information

for the Period Ended 31 December 2023




Director: Marcelina Jaskowiak
Registered office: Office 56
Millmead Business Centre
Millmead Road
London
Tottenham
GBR
N17 9QU
Company Registration Number: 14538924 (England and Wales)

LONDON SKIN MED MARCI LTD

Directors' Report Period Ended 31 December 2023

The directors present their report with the financial statements of the company for the period ended 31 December 2023

Principal Activities

The company's principal activities during the tax year under review were rendering services defined under SIC code 73110 of advertising agency as well as 73120 media representation services in wellness and beauty treatment sector.

Political and charitable donations

No contributions to political organizations nor charitable donations were made during the year.

Company policy on the employment of disabled persons

It is the company’s policy to give employment to disabled persons wherever practicable. At present, with regret, none of our full time/part time staff is registered disabled but whenever required we are looking forward to entrusting professional support in a variety of business-related fields to disabled freelancers.

Additional information

The accounts do not include a cash flow statement because the company as a small reporting entity is exempt from the requirement to prepare such a statement. Transactions in foreign currencies are recorded at the rate ruling at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are translated at the rate of exchange ruling at the balance sheet date. All differences are taken to the profit and loss account. Income earned in a currency other than Sterling was subjected to conversion to the British Pound at the exchange rate of the day on which payment was made and through the platform assisting with such exchange. Any costs associated with the operation of currency exchange of funds from foreign currency to the British Pound have been recorded as interest payable or banking fees.

Directors

The director(s) shown below were appointed to the company during the period
Marcelina Jaskowiak
13 December 2022

This report was approved by the board of directors on 13 September 2024
And Signed On Behalf Of The Board By:

Name: Marcelina Jaskowiak
Status: Director

LONDON SKIN MED MARCI LTD

Profit and Loss Account

for the Period Ended 31 December 2023


Notes
13 months to
31 Dec 2023
£
Turnover 52,190
Gross Profit or (Loss) 52,190
Operating Profit or (Loss) 52,190
Profit or (Loss) Before Tax 4 52,190
Tax on Profit ( 13,127 )
Profit or (Loss) for Period 39,063

The notes form part of these financial statements

LONDON SKIN MED MARCI LTD

Balance sheet

As at 31 December 2023


Notes
13 months to
31 Dec 2023
£
Fixed assets
Total fixed assets: -
Current assets
Cash at bank and in hand: 52,190
Total current assets: 52,190
Net current assets (liabilities): 52,190
Total assets less current liabilities: 52,190
Provision for liabilities: ( 13,127 )
Total net assets (liabilities): 39,063

The notes form part of these financial statements

LONDON SKIN MED MARCI LTD

Balance sheet continued

As at 31 December 2023


Notes
13 months to
31 Dec 2023
£
Capital and reserves
Called up share capital: 1
Profit and loss account: 39,062
Shareholders funds: 39,063

For the year ending 31 December 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 13 September 2024
And Signed On Behalf Of The Board By:

Name: Marcelina Jaskowiak
Status: Director

The notes form part of these financial statements

LONDON SKIN MED MARCI LTD

Notes to the Financial Statements

for the Period Ended 31 December 2023

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

    Turnover policy

    The turnover shown in the profit and loss account represents revenue recognized by the company in respect of services supplied during the period, exclusive of Value Added Tax and trade discounts.

    Tangible fixed assets depreciation policy

    Depreciation on assets hasn't been applied in the following period.

    Intangible fixed assets amortisation policy

    Amortization on Intangible fixed assets hasn't occurred in this accounting period.

    Valuation information and policy

    Stocks and work in progress valuation is not applicable to the company's nature of business, therefore intentionally not taken into consideration in preparation of the accounts.

LONDON SKIN MED MARCI LTD

Notes to the Financial Statements

for the Period Ended 31 December 2023

  • 2. Employees

    13 months to
    31 Dec 2023
    Average number of employees during the period 0

LONDON SKIN MED MARCI LTD

Notes to the Financial Statements

for the Period Ended 31 December 2023

  • 3. Off balance sheet disclosure

    No

LONDON SKIN MED MARCI LTD

Notes to the Financial Statements

for the Period Ended 31 December 2023

4.Profit or (Loss) before tax

Revenue generated in the period 13.12.2022 - 31.12.2023 w/ CT @ 19% and SA @ 8.5% deductions.

LONDON SKIN MED MARCI LTD

Notes to the Financial Statements

for the Period Ended 31 December 2023

5. Dividends

13 months to
31 Dec 2023
£
Dividends paid 38,270

Dividends paid and received are included in the Company financial statements in the period in which the related dividends are actually paid or received or, in respect of the Company’s final dividend for the year, approved by shareholders. Provision of liabilities section reflect Corporation Tax @ 19% rate i.e. £8,531.00 as well as basic rate dividends tax @ 8.75% proportion i.e. £3,211.25 of Director's Self Assessment covered by the company as part of dividends distribution. The total amount of tax liabilities resulting from the achieved income and dividend distribution during the period is £11,742.00.